And The Stock Is Up On Moderate Volume?????
The generic version was expected -- the only surprise was that it was a month or so late. Astex's value is not in the past -- it is in the future. Pipeline vs cash flow. -- in this cash pipeline wins.
See today's NY Times -- Astex was not mentioned but it sure was described.
Astex's pipeline is very robust. Also, many people may choose to buy the more expensive Dacogen. They trust it better.
Once the generic is available the insurance companies will force its use. Individuals are not paying for Dacogen -- insurance companies are.